Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.
Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (53)
- Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression 2026-11-01 · Expand citations
- Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression 2026-11-01 · Expand citations
- Substantial Treatment-Seeking Interest, Narrow Eligibility: Diagnostic Heterogeneity and External Validity in the PRIDE Psilocybin Trial-Relevance to Precision Psychiatry 2026-10-26 · Expand citations
- Clinical Evidence on Psilocybin and Its Representation in Media Reporting 2026-10-20 · Expand citations
- The New Mexico Medical Psilocybin Act and current trends in the United States psychedelic policy 2026-10-01 · Expand citations
- Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review 2026-09-10 · Expand citations
- Beyond Efficacy Signals: Regulatory, Methodological, and Translational Challenges in Clinical Research on Ketamine and Psilocybin in Psychiatry 2026-09-01 · Expand citations
- PSYCHEDELICS IN THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND DEPRESSION: A REVIEW OF CLINICAL TRIALS 2026-08-31 · Expand citations
- No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study 2026-07-23 · Expand citations
- Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview 2026-07-13 · Expand citations
- Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex 2026-06-28 · Expand citations
- DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish 2026-06-18 · Expand citations
- Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis 2026-06-15 · Expand citations
- Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations 2026-06-01 · Expand citations
- Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats 2026-06-01 · Expand citations
- Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial 2026-06-01 · Expand citations
- Psilocybin: Chemical Foundations and Emerging Therapeutic Potential 2026-06-01 · Expand citations
- Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial 2026-05-27 · Expand citations
- Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression 2026-05-15 · Expand citations
- The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes 2026-04-21 · Expand citations
- Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications 2026-04-01 · Expand citations
- Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies 2026-03-19 · Expand citations
- Explainable AI framework for psilocybin depression treatment optimization 2026-03-16 · Expand citations
- Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy 2026-03-01 · Expand citations
- A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations 2026-02-28 · Expand citations
- PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION 2026-01-28 · Expand citations
- A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens 2025-11-14 · Expand citations
- Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are required 2025-11-04 · Expand citations
- Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder 2025-09-04 · Expand citations
- PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH 2025-09-01 · Expand citations
- Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report 2025-09-01 · Expand citations
- Is there mush-room to improve the environmental sustainability of psilocybin production? 2025-06-10 · Expand citations
- Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung 2025-05-01 · Expand citations
- Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis 2025-04-24 · Expand citations
- BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW 2025-02-20 · Expand citations
- “The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybin 2024-10-29 · Expand citations
- Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-Analysis 2024-10-03 · Expand citations
- Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms 2024-09-09 · Expand citations
- Resurrecting Ancestral Familial Health: A Role for Psilocybin? 2024-08-09 · Expand citations
- Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometry 2024-02-01 · Expand citations
- Psilocybin and eugenol prevent DSS-induced neuroinflammation in mice 2024-01-25 · Expand citations
- How should psychotherapy proceed when adjoined with psychedelics? 2024-01-12 · Expand citations
- Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental Disorders 2024-01-01 · Expand citations
- Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol 2023-10-25 · Expand citations
- Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training 2023-09-08 · Expand citations
- Psilocybin's Emerging Role in Combating Depressive Disorder 2023-08-08 · Expand citations
- A regulatory framework review of Schedule I psychedelics in the United States 2023-06-12 · Expand citations
- Psilocybin therapy: A novel approach to treating depression 2023-06-02 · Expand citations
- A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history 2023-04-26 · Expand citations
- From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia 2022-12-31 · Expand citations
- The psychedelic escape from depression 2022-09-27 · Expand citations
- Psychedelics in the Treatment of Substance Use Disorders 2022-09-01 · Expand citations
- Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions 2022-06-09 · Expand citations